Maccura Biotechnology Co Stock Current Liabilities
300463 Stock | 13.94 0.07 0.50% |
Maccura Biotechnology Co fundamentals help investors to digest information that contributes to Maccura Biotechnology's financial success or failures. It also enables traders to predict the movement of Maccura Stock. The fundamental analysis module provides a way to measure Maccura Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Maccura Biotechnology stock.
At present, Maccura Biotechnology's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Non Current Liabilities Total is expected to grow to about 416.6 M, whereas Non Current Liabilities Other is forecasted to decline to about 3.3 M. Maccura | Current Liabilities |
Maccura Biotechnology Co Company Current Liabilities Analysis
Maccura Biotechnology's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
Maccura Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Maccura Biotechnology Co has a Current Liabilities of 0.0. This indicator is about the same for the Life Sciences Tools & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
All Next | Launch Module |
Maccura Fundamentals
Return On Equity | 0.0485 | ||||
Return On Asset | 0.0219 | ||||
Profit Margin | 0.12 % | ||||
Operating Margin | 0.17 % | ||||
Current Valuation | 8.38 B | ||||
Shares Outstanding | 612.47 M | ||||
Shares Owned By Insiders | 40.27 % | ||||
Shares Owned By Institutions | 4.76 % | ||||
Price To Book | 1.31 X | ||||
Price To Sales | 3.16 X | ||||
Revenue | 2.9 B | ||||
Gross Profit | 1.96 B | ||||
EBITDA | 613.34 M | ||||
Net Income | 312.62 M | ||||
Total Debt | 144.65 M | ||||
Book Value Per Share | 10.79 X | ||||
Cash Flow From Operations | 901.51 M | ||||
Earnings Per Share | 0.53 X | ||||
Target Price | 13.79 | ||||
Number Of Employees | 3.36 K | ||||
Beta | 0.38 | ||||
Market Capitalization | 8.61 B | ||||
Total Asset | 8.12 B | ||||
Retained Earnings | 3.84 B | ||||
Working Capital | 3.1 B | ||||
Annual Yield | 0.01 % | ||||
Net Asset | 8.12 B | ||||
Last Dividend Paid | 0.15 |
About Maccura Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Maccura Biotechnology Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maccura Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maccura Biotechnology Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Maccura Stock
Maccura Biotechnology financial ratios help investors to determine whether Maccura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maccura with respect to the benefits of owning Maccura Biotechnology security.